Global Pharmacy Automation Devices Market is Anticipated To Reach USD 11.6 Billion By 2032

The pharmacy automation devices market will grow from USD 5.72 Billion in 2022 to USD 11.60 Billion by 2032. The pharmacy automation devices market is witnessing a rise in demand due to the increasing requirement for automated dispensers and...

Daiichi To File For US Approval of New Lung Cancer Medicine

After showing a benefit in patients with advanced disease, Daiichi Sankyo Co. expects to file for US approval of its innovative lung cancer treatment by the end of March. Patients with non-small cell lung cancer who had progressed despite...

The Impact of Adjuvant Technology on Vaccine Development

Adjuvant technology can improve vaccination effectiveness by activating the immune system, resulting in a stronger immune response.

Salipro Biotech and Sumitomo Pharma Partner For Drug Discovery

Salipro Biotech and Sumitomo Pharma have formed a research partnership to better understand the pharmacological properties of a molecule from Sumitomo's drug discovery program. Both firms hope to improve Sumitomo's drug development program by...

GARDP Inks Sublicense Agreement with Orchid Pharma To Produce Antibiotic For Gram-negative Infections

The Global Antibiotic Research and Development Partnership (GARDP) and India-based Orchid Pharma Ltd (Orchid) have agreed to manufacture cefiderocol, an antibiotic used to treat certain Gram-negative infections. This agreement is a vital milestone...

NovaBay Pharma Announces an Agreement With BioStem To Commercialize Amniotic Tissue Allograft

NovaBay Pharmaceuticals, Inc. and BioStem Technologies, Inc. have announced an agreement under which NovaBay has been awarded the exclusive right to commercialize BioStem Technologies' Amniotic Tissue Allograft, which is designed to be used as a...

Sandoz Enters into an Agreement with Samsung Bioepis To commercialise Biosimilar Ustekinumab

Sandoz, a major producer in generic and biosimilar pharmaceuticals, has signed a development and commercialization cooperation with Samsung Bioepis. According to the company's statement, the deal grants Sandoz exclusive rights to commercialize the...

Indian Pharma Sector To Record 8 to 10 Percent Revenue Growth This Fiscal says Crisil

The Indian pharmaceuticals industry is expected to log in a revenue growth of 8-10 per cent in current fiscal aided by a steady domestic growth and increased exports to regulated markets, even as semi-regulated markets face headwinds. A study of...

Apollo Clinic Join Hands with Fix Health To Deliver AI-assisted Physiotherapy

Fix Health (formerly YourPhysio), a healthcare firm that specializes in AI-assisted physiotherapy, has teamed with Apollo Clinic. Through this collaboration, the clinic chain is offering professional care from throughout India to patients' homes...

Strides Pharma Gets USFDA Approval For Generic Sevelamer Carbonate Oral Suspension

Strides Pharma Science Ltd said that its Singapore subsidiary, Strides Pharma Global Pte Ltd, has gained approval from the US Food and Drug Administration for its generic Sevelamer Carbonate for oral suspension, which is indicated for patients...

© 2024 India Pharma Outlook. All Rights Reserved.